• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎即时检测的专业身份与新技术

Professional identities and new technologies of hepatitis C point-of-care testing.

作者信息

Conway Anna, Marshall Alison D, Grebely Jason, Fontaine Guillaume, Treloar Carla

机构信息

The Kirby Institute, UNSW, Sydney, Australia.

The Kirby Institute, UNSW, Sydney, Australia; Centre for Social Research in Health, UNSW, Sydney, Australia.

出版信息

Soc Sci Med. 2025 Aug;378:118140. doi: 10.1016/j.socscimed.2025.118140. Epub 2025 May 1.

DOI:10.1016/j.socscimed.2025.118140
PMID:40367644
Abstract

BACKGROUND

New hepatitis C virus (HCV) point-of-care testing technologies need models of care which involve new tasks to be performed by the health workforce (e.g., pathologists, community health workers, and peer workers). This change in tasks may challenge existing core patterns of work and professional identities. This study explores the interactions between professional identity and new technologies of HCV point-of-care testing.

METHODS

Between September 2023 and January 2024, in-depth, semi-structured interviews were conducted with people involved in HCV policymaking in Australia. The sample consisted of 29 participants working in seven Australian jurisdictions or nationally: 13 from departments of health, six from community-led organisations, five from local health districts, and five from pathology services. Data were coded according to themes identified in a prior conceptual review of professional identity. Analysis explored the bidirectional relationship between professional identities and the implementation of point-of-care testing.

RESULTS

Three themes were identified which explain the role of professional identity in influencing implementation of HCV point-of-care testing. Everyday interpersonal interactions influenced perceptions of risk. Maintaining high quality in point-of-care testing is valued across professions but the interpretation of quality is varied. Workers who deliver services directly to people at risk of HCV emphasise agility as a characteristic of their group identity which also distinguishes them from other professions.

CONCLUSION

Professional identities are shaping the rollout of HCV point-of-care testing. The prioritisation of risk, agility, and quality in professional identities shape the possibilities for HCV point-of-care testing. The analysis demonstrates the inextricability of new technology from the people who deliver it.

摘要

背景

新型丙型肝炎病毒(HCV)即时检测技术需要护理模式,其中涉及卫生工作人员(如病理学家、社区卫生工作者和同伴工作者)执行的新任务。任务的这种变化可能会挑战现有的核心工作模式和职业身份。本研究探讨职业身份与HCV即时检测新技术之间的相互作用。

方法

2023年9月至2024年1月期间,对澳大利亚参与HCV政策制定的人员进行了深入的半结构化访谈。样本包括在澳大利亚七个司法管辖区或全国范围内工作的29名参与者:13名来自卫生部门,6名来自社区主导组织,5名来自当地卫生区,5名来自病理服务部门。数据根据先前对职业身份的概念性综述中确定的主题进行编码。分析探讨了职业身份与即时检测实施之间的双向关系。

结果

确定了三个主题,解释了职业身份在影响HCV即时检测实施中的作用。日常人际互动影响了风险认知。在即时检测中保持高质量在各专业中都受到重视,但对质量的解释各不相同。直接为有HCV感染风险的人提供服务的工作人员强调灵活性是其群体身份的一个特征,这也使他们与其他专业有所区别。

结论

职业身份正在塑造HCV即时检测的推广。职业身份中对风险、灵活性和质量的优先排序塑造了HCV即时检测的可能性。分析表明新技术与提供技术的人员密不可分。

相似文献

1
Professional identities and new technologies of hepatitis C point-of-care testing.丙型肝炎即时检测的专业身份与新技术
Soc Sci Med. 2025 Aug;378:118140. doi: 10.1016/j.socscimed.2025.118140. Epub 2025 May 1.
2
Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers.运用交叉性视角探讨丙型肝炎即时检测的障碍和促成因素:一项针对注射吸毒者和服务提供者的定性研究。
Int J Equity Health. 2024 Jun 17;23(1):124. doi: 10.1186/s12939-024-02209-0.
3
Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection.丙型肝炎感染风险人群中使用即时检测和干血斑采集进行丙型肝炎检测的可接受性。
Int J Drug Policy. 2025 Mar;137:104720. doi: 10.1016/j.drugpo.2025.104720. Epub 2025 Jan 31.
4
Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia.患者和医疗保健提供者对澳大利亚原住民社区控制的健康服务机构中指尖即时检测丙型肝炎的可接受性的看法。
Int J Drug Policy. 2024 Mar;125:104335. doi: 10.1016/j.drugpo.2024.104335. Epub 2024 Feb 10.
5
"It's not just running the test": Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in Australia.
Int J Drug Policy. 2025 Jun;140:104800. doi: 10.1016/j.drugpo.2025.104800. Epub 2025 Apr 16.
6
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.从针具和注射器项目进行即时丙肝检测:澳大利亚可行性研究。
Int J Drug Policy. 2019 Oct;72:91-98. doi: 10.1016/j.drugpo.2019.05.012. Epub 2019 May 22.
7
"That was quick, simple, and easy": Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison.“既快速又简单还轻松”:在收押监狱中,患者对即时检测丙型肝炎 RNA 检测的可接受性的看法。
Int J Drug Policy. 2022 Jan;99:103456. doi: 10.1016/j.drugpo.2021.103456. Epub 2021 Sep 21.
8
"Quick, simple, and friendly": Understanding the acceptability and accessibility of a nurse and peer-led, mobile model of hepatitis C care adjacent to community corrections in Australia.“快速、简单且友好”:理解澳大利亚一种由护士和同伴主导的、临近社区矫正机构的丙型肝炎移动护理模式的可接受性和可及性。
Int J Drug Policy. 2025 May;139:104785. doi: 10.1016/j.drugpo.2025.104785. Epub 2025 Mar 26.
9
Findings from a Project Which Established Hepatitis C Point-of-Care Testing and Linkage to Care at a Homelessness Service in Adelaide, Australia, 2021-2022.2021年至2022年在澳大利亚阿德莱德一家无家可归者服务机构开展丙型肝炎即时检测及与护理衔接项目的研究结果。
Viruses. 2024 Dec 4;16(12):1882. doi: 10.3390/v16121882.
10
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.在由同伴主导的针头和注射器项目中,对近期有注射吸毒史的人群进行丙型肝炎即时检测、与护理服务的衔接以及同伴支持治疗:TEMPO试点研究。
Int J Drug Policy. 2023 Apr;114:103982. doi: 10.1016/j.drugpo.2023.103982. Epub 2023 Feb 28.

引用本文的文献

1
Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D.乙型、丙型和丁型肝炎的发病机制、预防及治疗进展
Virol J. 2025 Aug 11;22(1):274. doi: 10.1186/s12985-025-02907-3.